EC_number	Organism_name	Protein_file	Mol_file	pH	Temperature	Km_value_with_ref	Value_to_be_retained_for_model	pH	Temperature	Error	Comments
1.1.1.100	Cupriavidus necator	3VZS_A_A:Q47L_mut.pdb	mol_93.sdf	8	30°C	[(0.617, '56'), (0.289, '56'), (0.289, '56'), (0.617, '56')]	(0.289, '56')	8	30°C	-----	Wrong mutation mapping in BRENDA
1.1.1.184	Candida parapsilosis	3CTM_A_A:V270D_mut.pdb	mol_138.sdf	5	35°C	[(0.71, '80'), (8.45, '80'), (8.45, '80'), (0.71, '80')]	(0.71, '80')	5	35°C	-----	Difference in cofactor of the enzyme
1.1.1.184	Candida parapsilosis	3CTM_A_A:S172T_mut.pdb	mol_138.sdf	5	35°C	[(0.68, '80'), (8.67, '80'), (8.67, '80'), (0.68, '80')]	(0.68, '80')	5	35°C	-----	Difference in cofactor of the enzyme
1.1.1.184	Candida parapsilosis	3CTM_A_A:S67D+A:H68D_mut.pdb	mol_138.sdf	-----	-----	"[(0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (10.27, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}""), (0.76, ""{70: 'Ser67Asp and His68Asp substitutions in candida parapsilosis carbonyl reductase alter the coenzyme specificity and enantioselectivity of ketone reduction. Appl. Environ,2009', 80: 'Crystal structure of a carbonyl reductase from Candida parapsilosis with anti-Prelog stereospecificity,2008'}"")]"	(10.27, '70')	5	35°C	-----	Difference in cofactor of the enzyme
1.1.1.286	Thermococcus kodakarensis	5HN3_A_A:L83R_mut.pdb	mol_11.sdf	8	60°C	[(0.16, '8'), (0.62, '8'), (0.62, '8'), (0.16, '8')]	-----	8	60°C	-----	Difference in co-substrates for the reaction
1.1.1.286	Thermococcus kodakarensis	5HN3_A_A:L81P_mut.pdb	mol_11.sdf	8	60°C	[(0.6, '8'), (1.3, '8'), (0.6, '8'), (0.32, '8'), (1.3, '8'), (0.6, '8'), (1.3, '8'), (0.32, '8'), (0.32, '8'), (0.6, '8'), (0.32, '8'), (1.3, '8')]	-----	8	60°C	-----	Difference in co-substrates for the reaction
1.1.1.286	Thermococcus kodakarensis	5HN3_A_A:T71V_mut.pdb	mol_11.sdf	8	60°C	"[(1.0, '8'), (0.25, '8'), (1.0, '8'), (1.5, ""{8: 'Structure and function of an ancestral-type beta-decarboxylating dehydrogenase from Thermococcus kodakarensis. Biochem,2017'}""), (0.25, '8'), (1.0, '8'), (0.25, '8'), (1.5, ""{8: 'Structure and function of an ancestral-type beta-decarboxylating dehydrogenase from Thermococcus kodakarensis. Biochem,2017'}""), (1.5, ""{8: 'Structure and function of an ancestral-type beta-decarboxylating dehydrogenase from Thermococcus kodakarensis. Biochem,2017'}""), (1.0, '8'), (1.5, ""{8: 'Structure and function of an ancestral-type beta-decarboxylating dehydrogenase from Thermococcus kodakarensis. Biochem,2017'}""), (0.25, '8')]"	-----	8	60°C	-----	Difference in co-substrates for the reaction
1.1.1.286	Thermococcus kodakarensis	5HN3_A_A:I82N_mut.pdb	mol_11.sdf	8	60°C	[(1.8, '8'), (0.64, '8'), (0.64, '8'), (1.8, '8')]	-----	8	60°C	-----	Difference in co-substrates for the reaction
1.1.1.363	Leuconostoc mesenteroides	1E7Y_A_A:K22Q_mut.pdb	mol_200.sdf	7.6	25°C	[(2.5, '28'), (6.07, '28'), (6.07, '28'), (2.5, '28')]	(6.07, '28')	7.6	25°C	-----	Difference in cofactor of the enzyme
1.1.1.363	Leuconostoc mesenteroides	1E7Y_A_A:K22R_mut.pdb	mol_200.sdf	7.6	25°C	"[(0.097, '28'), (0.239, ""{14: 'Delineation of the roles of amino acids involved in the catalytic functions of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase,2000', 28: 'Lysine-21 of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase participates in substrate binding through charge-charge interaction,1992'}""), (0.239, ""{14: 'Delineation of the roles of amino acids involved in the catalytic functions of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase,2000', 28: 'Lysine-21 of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase participates in substrate binding through charge-charge interaction,1992'}""), (0.097, '28')]"	(0.239, '14')	7.6	25°C	-----	Difference in cofactor of the enzyme
1.1.1.6	Thermotoga maritima	1KQ3_A_A:V44A+A:K157G_mut.pdb	mol_457.sdf	7.4	50°C	"[(0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.25, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.186, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}"")]"	(0.25, '50')	7.4	50°C	-----	Wrong mutation mapping in our code
1.1.1.6	Thermotoga maritima	1KQ3_A_A:I154A_mut.pdb	mol_457.sdf	7.4	50°C	"[(0.73, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (2.9, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}""), (0.73, ""{50: 'Characterization of Thermotoga maritima glycerol dehydrogenase for the enzymatic production of dihydroxyacetone. Appl. Microbiol,2014'}"")]"	(0.73, '50')	7.4	50°C	-----	Wrong mutation mapping in our code
1.1.2.3	Saccharomyces cerevisiae	1KBI_B_B:H453Q_mut.pdb	mol_328.sdf	-----	-----	[(0.25, '35'), (0.65, '35'), (0.65, '35'), (0.25, '35')]	(0.25, '35')	-----	-----	-----	Value of only the flavin domain of the protein considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K206G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.1, '38'), (36.2, '38'), (36.2, '38'), (0.1, '38')]	(0.1, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K206G_mut.pdb	mol_632.sdf	3.5	25°C	"[(0.383, '38'), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.383, '38')]"	(0.0054, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:P171G+A:K206G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38'), (0.0362, '38'), (0.41, '38')]	(0.0362, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G_mut.pdb	mol_632.sdf	3.5	25°C	[(0.0143, '38'), (0.305, '38'), (0.305, '38'), (0.0143, '38')]	(0.0143, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K245Q_mut.pdb	mol_632.sdf	3.5	25°C	[(0.008, '38'), (1.66, '38'), (1.66, '38'), (0.008, '38')]	(0.008, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K206D_mut.pdb	mol_658.sdf	3.5	25°C	[(0.013, '38'), (0.42, '38'), (0.42, '38'), (0.013, '38')]	(0.013, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:P171G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.04, '38'), (1.114, '38'), (1.114, '38'), (0.04, '38')]	(0.04, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:F172G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.0059, '38'), (0.38, '38'), (0.38, '38'), (0.0059, '38')]	(0.0059, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:P106G_mut.pdb	mol_632.sdf	3.5	25°C	[(0.0023, '38'), (2.86, '38'), (2.86, '38'), (0.0023, '38')]	(0.0023, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.066, '38'), (37.4, '38'), (37.4, '38'), (0.066, '38')]	(0.066, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:P171G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.104, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (0.104, '38'), (16.0, '38'), (0.104, '38')]	(0.104, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K206G_mut.pdb	mol_658.sdf	3.5	25°C	[(1.05, '38'), (0.0189, '38'), (0.0189, '38'), (1.05, '38')]	(0.0189, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:P171G+A:K206G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38'), (2.38, '38'), (0.119, '38')]	(0.119, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:P171G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.155, '38'), (76.0, '38'), (76.0, '38'), (0.155, '38')]	(0.155, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.0205, '38'), (0.836, '38'), (0.836, '38'), (0.0205, '38')]	(0.0205, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:P171G_mut.pdb	mol_658.sdf	3.5	25°C	[(1.18, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (1.18, '38'), (0.0397, '38'), (1.18, '38')]	(0.0397, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:P106G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.0103, '38'), (1.026, '38'), (1.026, '38'), (0.0103, '38')]	(0.0103, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K206D_mut.pdb	mol_632.sdf	3.5	25°C	"[(2.23, '38'), (0.004, ""{21: 'Site-directed mutagenesis of the catalytic tryptophan environment in Pleurotus eryngii versatile peroxidase,2008', 38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.004, ""{21: 'Site-directed mutagenesis of the catalytic tryptophan environment in Pleurotus eryngii versatile peroxidase,2008', 38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (2.23, '38')]"	(0.004, '21')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K245Q_mut.pdb	mol_658.sdf	3.5	25°C	[(1.02, '38'), (0.0122, '38'), (0.0122, '38'), (1.02, '38')]	(0.0122, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:F172G_mut.pdb	mol_632.sdf	3.5	25°C	[(0.0041, '38'), (0.828, '38'), (0.828, '38'), (0.0041, '38')]	(0.0122, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:K206G_mut.pdb	mol_631.sdf	3.5	25°C	[(0.189, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (0.189, '38'), (2.97, '38'), (0.189, '38')]	(0.189, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K245Q_mut.pdb	mol_631.sdf	3.5	25°C	"[(2.56, '38'), (0.078, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.078, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (2.56, '38')]"	(0.078, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K245G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.0174, '38'), (1.112, '38'), (1.112, '38'), (0.0174, '38')]	(0.0174, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:P171G_mut.pdb	mol_632.sdf	3.5	25°C	"[(0.461, '38'), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.461, '38')]"	(0.0054, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:E170G+A:K206G_mut.pdb	mol_658.sdf	3.5	25°C	[(0.0251, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.0251, '38'), (0.618, '38'), (0.0251, '38')]	(0.0251, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.11.1.16	Pleurotus eryngii	3FM1_A_A:K245G_mut.pdb	mol_632.sdf	3.5	25°C	"[(0.0836, '38'), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.0054, ""{38: 'Two oxidation sites for low redox potential substrates: a directed mutagenesis, kinetic, and crystallographic study on Pleurotus eryngii versatile peroxidase. J. Biol,2012'}""), (0.0836, '38')]"	(0.0054, '38')	3.5	25°C	-----	Value at the high-efficiency site of the enzyme considered
1.14.20.1	Streptomyces clavuligerus	1HJG_A_A:Q258A_mut.pdb	mol_1105.sdf	7.5	-----	[(1.8, '5'), (0.79, '5'), (0.79, '5'), (1.8, '5')]	(1.8, '5')	7.5	-----	-----	Wrong mutation mapping in our code
1.14.20.1	Streptomyces clavuligerus	1HJG_A_A:Q258F_mut.pdb	mol_1103.sdf	7.5	-----	[(1.9, '5'), (0.79, '5'), (0.79, '5'), (1.9, '5')]	-----	-----	-----	Both values are wrong	-----
1.2.3.1	Mus musculus	3ZYV_A_A:F776K+A:A807E+A:D878L+A:L881S+A:Y885R+A:K889H+A:P1015T+A:Y1019L_mut.pdb	mol_1250.sdf	8.037°C	8.037°C	[(0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134'), (2.93, '134'), (0.133, '134')]	-----	8	37°C	Both values are wrong	-----
1.3.3.3	Homo sapiens	2AEX_A_A:R401A_mut.pdb	mol_1359.sdf	-----	-----	"[(0.00096, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.0029, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.0029, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.00096, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}"")]"	(0.0029, '63')	-----	37°C	-----	Value for total product formation considered
1.3.3.3	Homo sapiens	2AEX_A_A:R401A_mut.pdb	mol_1359.sdf	-----	37°C	"[(0.0029, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.00096, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.00096, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}""), (0.0029, ""{63: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007', 84: 'Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase,2007'}"")]"	(0.0029, '63')	-----	37°C	-----	Value for total product formation considered
1.4.3.5	Escherichia coli	1DNL_A_A:R197M_mut.pdb	mol_1508.sdf	-----	-----	[(0.09, '40'), (2.4, '40'), (2.4, '40'), (0.09, '40')]	(0.09, '40')	-----	-----	-----	Wrong mutation mapping in BRENDA
1.5.3.1	Bacillus sp. (in: Bacteria)	2GF3_A_A:R50K_mut.pdb	mol_1430.sdf	8	25°C	[(0.01, '46'), (28.8, '46'), (28.8, '46'), (0.01, '46')]	(28.8, '46')	8	25°C	-----	Wrong substrate mapping in BRENDA
2.4.1.133	Homo sapiens	4IRP_A_A:E227D_mut.pdb	mol_2088.sdf	7	37°C	"[(0.1, '31'), (0.47, ""{31: 'Identification of key functional residues in the active site of human {beta}1,4-galactosyltransferase 7: a major enzyme in the glycosaminoglycan synthesis pathway. J. Biol,2010'}""), (0.47, ""{31: 'Identification of key functional residues in the active site of human {beta}1,4-galactosyltransferase 7: a major enzyme in the glycosaminoglycan synthesis pathway. J. Biol,2010'}""), (0.1, '31')]"	(0.1, '31')	7	37°C	-----	Value when protein is expressed in E.coli considered
2.4.1.133	Homo sapiens	4IRP_A_A:W224H_mut.pdb	mol_2088.sdf	7	37°C	"[(0.02, '31'), (0.07, ""{31: 'Identification of key functional residues in the active site of human {beta}1,4-galactosyltransferase 7: a major enzyme in the glycosaminoglycan synthesis pathway. J. Biol,2010'}""), (0.07, ""{31: 'Identification of key functional residues in the active site of human {beta}1,4-galactosyltransferase 7: a major enzyme in the glycosaminoglycan synthesis pathway. J. Biol,2010'}""), (0.02, '31')]"	(0.02, '31')	7	37°C	-----	Value when protein is expressed in E.coli considered
2.4.2.8	Homo sapiens	4RAO_A_A:F35L_mut.pdb	mol_2312.sdf	7.4	22°C	[(0.001, '44'), (0.027, '44'), (0.001, '44'), (0.041, '44'), (0.027, '44'), (0.001, '44'), (0.027, '44'), (0.041, '44'), (0.041, '44'), (0.001, '44'), (0.041, '44'), (0.027, '44')]	(0.027, '44')	7.4	22°C	-----	Value with hypoxanthine as co-substrate considered
2.4.2.8	Homo sapiens	4RAO_A_A:F35K_mut.pdb	mol_2312.sdf	7.4	22°C	[(0.029, '44'), (0.0044, '44'), (0.0044, '44'), (0.029, '44')]	(0.0044, '44')	7.4	22°C	-----	Value with hypoxanthine as co-substrate considered
2.4.2.8	Homo sapiens	4RAO_A_A:F35G_mut.pdb	mol_2312.sdf	7.4	22°C	[(0.011, '44'), (0.05, '13,44'), (0.05, '13,44'), (0.011, '44')]	(0.011, '44')	7.4	22°C	-----	Value with hypoxanthine as co-substrate considered
2.4.3.6	Pasteurella multocida	2IY7_A_A:M144D_mut.pdb	mol_2363.sdf	8.5	37°C	[(0.3, '1'), (2.1, '1'), (0.3, '1'), (7.3, '1'), (2.1, '1'), (0.3, '1'), (2.1, '1'), (7.3, '1'), (7.3, '1'), (0.3, '1'), (7.3, '1'), (2.1, '1')]	(7.3, '1')	8.5	37°C	-----	Value without any cosubstrates considered
2.4.3.6	Pasteurella multocida	2IY7_A_A:M144H_mut.pdb	mol_2363.sdf	8.5	37°C	[(0.4, '1'), (0.81, '1'), (0.4, '1'), (13.0, '1'), (0.81, '1'), (0.4, '1'), (0.81, '1'), (13.0, '1'), (13.0, '1'), (0.4, '1'), (13.0, '1'), (0.81, '1')]	(13.0, '1')	8.5	37°C	-----	Value without any cosubstrates considered
2.5.1.18	Homo sapiens	5J41_A_A:I105V+A:A114V_mut.pdb	mol_695.sdf	6.5	-----	"[(0.003, '178'), (0.08, '178'), (0.003, '178'), (0.2, ""{136: 'Purification and biochemical characterization of cytosolic glutathione-S-transferase from malarial parasites Plasmodium yoelii. Parasitol,2007', 151: 'Glutathione transferases from parasites: a biochemical view,2008', 155: 'Cooperative kinetics of the recombinant glutathione transferase of Taenia solium and characterization of the enzyme. Arch. Biochem,2008', 170: 'Purification and partial characterization of glutathione transferase from the teleost Monopterus albus. Comp. Biochem. Physiol,2008', 178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008'}""), (0.08, '178'), (0.003, '178'), (0.08, '178'), (0.2, ""{136: 'Purification and biochemical characterization of cytosolic glutathione-S-transferase from malarial parasites Plasmodium yoelii. Parasitol,2007', 151: 'Glutathione transferases from parasites: a biochemical view,2008', 155: 'Cooperative kinetics of the recombinant glutathione transferase of Taenia solium and characterization of the enzyme. Arch. Biochem,2008', 170: 'Purification and partial characterization of glutathione transferase from the teleost Monopterus albus. Comp. Biochem. Physiol,2008', 178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008'}""), (0.2, ""{136: 'Purification and biochemical characterization of cytosolic glutathione-S-transferase from malarial parasites Plasmodium yoelii. Parasitol,2007', 151: 'Glutathione transferases from parasites: a biochemical view,2008', 155: 'Cooperative kinetics of the recombinant glutathione transferase of Taenia solium and characterization of the enzyme. Arch. Biochem,2008', 170: 'Purification and partial characterization of glutathione transferase from the teleost Monopterus albus. Comp. Biochem. Physiol,2008', 178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008'}""), (0.003, '178'), (0.2, ""{136: 'Purification and biochemical characterization of cytosolic glutathione-S-transferase from malarial parasites Plasmodium yoelii. Parasitol,2007', 151: 'Glutathione transferases from parasites: a biochemical view,2008', 155: 'Cooperative kinetics of the recombinant glutathione transferase of Taenia solium and characterization of the enzyme. Arch. Biochem,2008', 170: 'Purification and partial characterization of glutathione transferase from the teleost Monopterus albus. Comp. Biochem. Physiol,2008', 178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008'}""), (0.08, '178')]"	-----	6.5	-----	Difference in cosubstrates of the enzyme	-----
2.5.1.18	Homo sapiens	5J41_A_A:A114V_mut.pdb	mol_695.sdf	6.5	-----	"[(0.21, '178'), (0.014, '178'), (0.21, '178'), (0.13, ""{178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008', 257: 'New food for an old mouth: new enzyme for an ancient archaea. Enzyme Microb,2014'}""), (0.014, '178'), (0.21, '178'), (0.014, '178'), (0.13, ""{178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008', 257: 'New food for an old mouth: new enzyme for an ancient archaea. Enzyme Microb,2014'}""), (0.13, ""{178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008', 257: 'New food for an old mouth: new enzyme for an ancient archaea. Enzyme Microb,2014'}""), (0.21, '178'), (0.13, ""{178: 'The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol,2008', 257: 'New food for an old mouth: new enzyme for an ancient archaea. Enzyme Microb,2014'}""), (0.014, '178')]"	-----	6.5	-----	Difference in cosubstrates of the enzyme	-----
2.5.1.55	Neisseria meningitidis	3FYO_D_D:C23C+D:C246S_mut.pdb	mol_2444.sdf	7.4	37°C	[(0.05, '45'), (0.0066, '45'), (0.0066, '45'), (0.05, '45')]	(0.0066, '45')	7.4	37°C	-----	Value of mutant considered and mutant control discarded
2.5.1.55	Neisseria meningitidis	3FYO_D_D:C23C+D:A249A_mut.pdb	mol_2480.sdf	7.4	37°C	[(0.013, '45'), (0.109, '45'), (0.109, '45'), (0.013, '45')]	(0.013, '45')	7.4	37°C	-----	Value of mutant considered and mutant control discarded
2.5.1.55	Neisseria meningitidis	3FYO_D_D:C23C+D:C246S_mut.pdb	mol_2480.sdf	7.4	37°C	[(0.097, '45'), (1.04, '45'), (1.04, '45'), (0.097, '45')]	(0.097, '45')	7.4	37°C	-----	Value of mutant considered and mutant control discarded
2.5.1.6	Rattus norvegicus	1QM4_A_A:C35S_mut.pdb	mol_2483.sdf	-----	-----	[(0.449, '51'), (0.222, '51'), (0.222, '51'), (0.449, '51')]	-----	-----	-----	Difference in cosubstrates of the enzyme	-----
2.6.1.1	Escherichia coli	1ART_A_A:A8T+A:P9T+A:N30D+A:T104S+A:G249A+A:S273G+A:A281D+A:N285S_mut.pdb	mol_337.sdf	8	-----	"[(0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75'), (2.6, ""{41: 'Purification and characterization of thermostable aspartate aminotransferase from a thermophilic Bacillus species. J,1990', 75: 'Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase,2004'}""), (0.48, '75')]"	(2.6, '41')	-----	-----	-----	Value with L-Asp as cosubstrate considered as per crystal structure
2.7.1.157	Homo sapiens	2A2C_A_A:F444A_mut.pdb	mol_810.sdf	7.5	37°C	[(0.025, '7'), (0.006, '7'), (0.025, '7'), (0.039, '7'), (0.006, '7'), (0.025, '7'), (0.006, '7'), (0.039, '7'), (0.039, '7'), (0.025, '7'), (0.039, '7'), (0.006, '7')]	(0.006, '7')	7.5	37°C	-----	Value with N-acetyl-D-galactosamine as co-substrate considered as per crystal structure
2.7.1.157	Homo sapiens	2A2C_A_A:F444S_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.13, '7'), (0.019, '7'), (0.13, '7'), (0.013, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.019, '7'), (0.13, '7'), (0.019, '7'), (0.013, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.013, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.13, '7'), (0.013, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.019, '7')]"	(0.019, '7')	7.5	37°C	-----	Value with N-acetyl-D-galactosamine as co-substrate considered as per crystal structure
2.7.1.157	Homo sapiens	2A2C_A_A:F444R_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.015, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.009, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.015, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.024, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.009, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.015, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.009, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.024, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.024, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.015, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.024, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}""), (0.009, ""{7: 'N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl. Biochem,2012'}"")]"	(0.009, '7')	7.5	37°C	-----	Value with N-acetyl-D-galactosamine as co-substrate considered as per crystal structure
2.7.1.25	Arabidopsis thaliana	3UIE_A_A:C86A+A:C119A_mut.pdb	mol_2606.sdf	7.5	25°C	[(0.0019, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.0019, '46'), (0.00087, '46'), (0.0019, '46')]	(0.0019, '46')	7.5	25°C	-----	Value with reduced form of enzyme considered as per crystal structure
2.7.1.6	Homo sapiens	6Q3X_A_A:L231S_mut.pdb	mol_810.sdf	7.5	37°C	[(0.0024, '52'), (0.0148, '52'), (0.0148, '52'), (0.0024, '52')]	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:Y379W_mut.pdb	mol_810.sdf	7.5	37°C	[(0.0037, '54'), (0.016, '54'), (0.0037, '54'), (5.0, '54'), (0.016, '54'), (0.0037, '54'), (0.016, '54'), (5.0, '54'), (5.0, '54'), (0.0037, '54'), (5.0, '54'), (0.016, '54')]	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:Q242S_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.0128, '52'), (0.0446, '52'), (0.0128, '52'), (0.0094, ""{51: '', 52: ''}""), (0.0446, '52'), (0.0128, '52'), (0.0446, '52'), (0.0094, ""{51: '', 52: ''}""), (0.0094, ""{51: '', 52: ''}""), (0.0128, '52'), (0.0094, ""{51: '', 52: ''}""), (0.0446, '52')]"	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:M185L+A:Y379W_mut.pdb	mol_810.sdf	7.5	37°C	[(0.0027, '54'), (11.4, '54'), (11.4, '54'), (0.0027, '54')]	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:M60V+A:M185L+A:M180V+A:D268E+A:A334S+A:R366Q+A:G373S+A:Y379W_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.0044, '54'), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0044, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54'), (0.004, ""{51: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (12.4, '54')]"	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:E245S_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.0077, '52'), (0.0132, '52'), (0.0077, '52'), (0.0392, '52'), (0.0077, '52'), (0.0594, ""{52: ''}""), (0.0132, '52'), (0.0077, '52'), (0.0132, '52'), (0.0392, '52'), (0.0132, '52'), (0.0594, ""{52: ''}""), (0.0392, '52'), (0.0077, '52'), (0.0392, '52'), (0.0132, '52'), (0.0392, '52'), (0.0594, ""{52: ''}""), (0.0594, ""{52: ''}""), (0.0077, '52'), (0.0594, ""{52: ''}""), (0.0132, '52'), (0.0594, ""{52: ''}""), (0.0392, '52')]"	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:M60V+A:M180V+A:D268E+A:A334S+A:R366Q+A:G373S+A:Y379W_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0134, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (0.0134, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (8.1, '54'), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0134, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (8.1, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0174, '54')]"	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.6	Homo sapiens	6Q3X_A_A:E244S_mut.pdb	mol_810.sdf	7.5	37°C	"[(0.0367, '52'), (0.0198, '52'), (0.0367, '52'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0367, '52'), (0.0594, ""{52: ''}""), (0.0198, '52'), (0.0367, '52'), (0.0198, '52'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0198, '52'), (0.0594, ""{52: ''}""), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0367, '52'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0198, '52'), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}""), (0.0594, ""{52: ''}""), (0.0594, ""{52: ''}""), (0.0367, '52'), (0.0594, ""{52: ''}""), (0.0198, '52'), (0.0594, ""{52: ''}""), (0.0066, ""{52: '', 54: 'Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications,2018'}"")]"	-----	7.5	37°C	Wrong substrate mapping in BRENDA	-----
2.7.1.74	Homo sapiens	7ZIA_A_A:C185A_mut.pdb	mol_810.sdf	7.6	-----	[(0.025, '61'), (0.087, '61'), (0.087, '61'), (0.025, '61')]	-----	7.6	-----	Difference in cosubstrates of the enzyme	-----
2.7.4.22	Escherichia coli	2BNE_A_A:N159N_mut.pdb	mol_811.sdf	-----	-----	"[(0.26, '20'), (0.2, '20'), (0.26, '20'), (0.19, '20'), (0.26, '20'), (0.77, '20'), (0.26, '20'), (0.24, '20'), (0.26, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.2, '20'), (0.26, '20'), (0.2, '20'), (0.19, '20'), (0.2, '20'), (0.77, '20'), (0.2, '20'), (0.24, '20'), (0.2, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.19, '20'), (0.26, '20'), (0.19, '20'), (0.2, '20'), (0.19, '20'), (0.77, '20'), (0.19, '20'), (0.24, '20'), (0.19, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.77, '20'), (0.26, '20'), (0.77, '20'), (0.2, '20'), (0.77, '20'), (0.19, '20'), (0.77, '20'), (0.24, '20'), (0.77, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.24, '20'), (0.26, '20'), (0.24, '20'), (0.2, '20'), (0.24, '20'), (0.19, '20'), (0.24, '20'), (0.77, '20'), (0.24, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.26, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.2, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.19, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.77, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.24, '20')]"	[(0.19, '20'), (0.21, '20')]	-----	-----	-----	Value with UMP as co-substrate considered as per crystal structure
2.7.4.22	Escherichia coli	2BNE_A_A:D93A+A:N159N_mut.pdb	mol_811.sdf	-----	-----	"[(0.41, '20'), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.41, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.41, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.36, '20'), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.41, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.36, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.64, '20'), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.27, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.59, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}"")]"	[(0.27, '20'), (0.36, '20')]	-----	-----	-----	Value with UMP as co-substrate considered as per crystal structure
2.7.4.22	Escherichia coli	2BNE_A_A:N140A+A:N159N_mut.pdb	mol_811.sdf	-----	-----	"[(0.25, '20'), (0.23, '20'), (0.25, '20'), (0.53, '20'), (0.25, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.23, '20'), (0.25, '20'), (0.23, '20'), (0.53, '20'), (0.23, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.53, '20'), (0.25, '20'), (0.53, '20'), (0.23, '20'), (0.53, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.25, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.23, '20'), (0.21, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.53, '20')]"	(0.25, '20')	-----	-----	-----	Value with UMP as co-substrate considered as per crystal structure
2.7.4.22	Escherichia coli	2BNE_A_A:D93A+A:N159N_mut.pdb	mol_2344.sdf	-----	-----	"[(0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0357, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0357, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0275, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0357, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0275, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0244, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0357, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0275, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0244, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0788, '20'), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0357, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0275, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0244, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0788, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20'), (0.0238, ""{20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0755, '20')]"	-----	-----	-----	Difference in cosubstrates of the enzyme	-----
2.7.4.22	Escherichia coli	2BNE_A_A:N140A+A:N159N_mut.pdb	mol_2344.sdf	-----	-----	"[(0.0739, '20'), (0.1812, '20'), (0.0739, '20'), (0.1086, '20'), (0.0739, '20'), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.1812, '20'), (0.0739, '20'), (0.1812, '20'), (0.1086, '20'), (0.1812, '20'), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.1086, '20'), (0.0739, '20'), (0.1086, '20'), (0.1812, '20'), (0.1086, '20'), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.0739, '20'), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.1812, '20'), (0.05, ""{3: 'Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP,1995', 5: 'UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J,2003', 9: 'Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol,2005', 15: 'Regulatory mechanisms differ in UMP kinases from Gram-negative and Gram-positive bacteria. J. Biol,2007', 20: 'Structural and functional characterization of Escherichia coli UMP kinase in complex with its allosteric regulator GTP. J. Biol,2008'}""), (0.1086, '20')]"	-----	-----	-----	Difference in cosubstrates of the enzyme	-----
2.7.7.72	Archaeoglobus fulgidus	1R89_A_A:P295G_mut.pdb	mol_2557.sdf	and	-----	"[(0.09, '22'), (0.01, ""{22: 'On the role of a conserved, potentially helix-breaking residue in the tRNA-binding alpha-helix of archaeal CCA-adding enzymes,2008'}""), (0.01, ""{22: 'On the role of a conserved, potentially helix-breaking residue in the tRNA-binding alpha-helix of archaeal CCA-adding enzymes,2008'}""), (0.09, '22')]"	[(0.09, '22'), (0.01, '22')]	-----	-----	-----	Both values are correct
2.8.2.1	Homo sapiens	3CKL_A_A:K266E_mut.pdb	mol_2855.sdf	7.4	37°C	[(0.0019, '116'), (0.00388, '116'), (0.00388, '116'), (0.0019, '116')]	(0.00388, '116')	7.4	37°C	-----	Wrong mutation mapping in our code
3.1.1.81	Bacillus thuringiensis	5EHT_A_A:C64C+A:F68C_mut.pdb	mol_3158.sdf	7.5	-----	"[(0.26, '40'), (0.7, ""{40: 'A phenylalanine clamp controls substrate specificity in the quorum-quenching metallo-gamma-lactonase from Bacillus thuringiensis,2013'}""), (0.7, ""{40: 'A phenylalanine clamp controls substrate specificity in the quorum-quenching metallo-gamma-lactonase from Bacillus thuringiensis,2013'}""), (0.26, '40')]"	(0.7, '40')	7.5	-----	-----	Value in absence of DTT considered as per crystal structure
3.1.1.81	Bacillus thuringiensis	5EHT_A_A:C64C+A:F68C_mut.pdb	mol_3159.sdf	7.5	-----	[(1.8, '40'), (4.5, '40'), (4.5, '40'), (1.8, '40')]	(4.5, '40')	7.5	-----	-----	Value in absence of DTT considered as per crystal structure
3.1.1.84	Rhodococcus sp.	3I2K_A_A:T172R+A:G173Q_mut.pdb	mol_3173.sdf	-----	37°C	"[(0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16'), (0.024, ""{5: 'Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol,2009'}""), (0.0029, '16')]"	(0.024, '5')	7.4	37°C	-----	Value of mutant without additional modifications considered
3.1.3.1	Escherichia coli	1B8J_A_A:D123A+A:E344Y_mut.pdb	mol_3004.sdf	8	25°C	[(0.15, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.15, '275'), (0.052, '275'), (0.15, '275')]	 (0.052, '275')	8	25°C	-----	Wrong mutation mapping in our code
3.2.1.169	Bacteroides thetaiotaomicron	5FKY_A_A:Y303F_mut.pdb	mol_3571.sdf	-----	-----	[(0.41, '17'), (1.18, '17'), (1.18, '17'), (0.41, '17')]	(0.41, '17')	-----	-----	-----	Wrong mutation mapping in our code
3.2.1.169	Bacteroides thetaiotaomicron	5FKY_A_A:D264N_mut.pdb	mol_3574.sdf	Km	-----	[(1.0, '13'), (0.08, '13'), (0.08, '13'), (1.0, '13')]	-----	-----	-----	Apparent Km values in BRENDA	-----
3.4.23.16	Human immunodeficiency virus 1	5YOK_A_A:K7K+A:I33I+A:I63I+A:A67A+A:A95A_mut.pdb	mol_4375.sdf	5.6	37°C	[(0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45'), (0.192, '45'), (0.021, '45')]	(0.021, '45')	5.6	37°C	-----	Value against complete enzyme considered instead of truncated enzyme
3.5.1.114	Mus musculus	3NH4_A_A:D235R_mut.pdb	mol_4530.sdf	7.5	-----	"[(0.55, '3'), (1.3, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (1.3, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (0.55, '3')]"	[(0.55, '3'), (1.3, '3')]	7.5	-----	-----	Effect of ions not considered for the model
3.5.1.114	Mus musculus	3NH4_A_A:Y156A_mut.pdb	mol_4530.sdf	7.5	-----	[(0.22, '3'), (0.79, '3'), (0.79, '3'), (0.22, '3')]	[(0.79, '3'), (0.22, '3')]	7.5	-----	-----	Effect of ions not considered for the model
3.5.1.114	Mus musculus	3NH4_A_A:R67D_mut.pdb	mol_4530.sdf	7.5	-----	"[(0.53, '3'), (0.26, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (0.26, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (0.53, '3')]"	[(0.53, '3'), (0.26, '3')]	7.5	-----	-----	Effect of ions not considered for the model
3.5.1.114	Mus musculus	3NH4_A_A:E167R_mut.pdb	mol_4530.sdf	7.5	-----	"[(0.61, '3'), (1.3, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (1.3, ""{3: 'Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim. Biophys,2009'}""), (0.61, '3')]"	[(0.61, '3'), (1.3, '3')] 	7.5	-----	-----	Effect of ions not considered for the model
3.5.1.114	Mus musculus	3NH4_A_A:E289A_mut.pdb	mol_4535.sdf	7.5	-----	[(3.4, '3'), (11.03, '3'), (11.03, '3'), (3.4, '3')]	[(3.4, '3'), (11.03, '3')]	7.5	-----	-----	Effect of ions not considered for the model
3.5.1.114	Mus musculus	3NH4_A_A:Y288A_mut.pdb	mol_4535.sdf	7.5	-----	[(6.76, '3'), (17.73, '3'), (17.73, '3'), (6.76, '3')]	[(6.76, '3'), (17.73, '3')]	7.5	-----	-----	Effect of ions not considered for the model
3.5.3.1	Homo sapiens	2AEB_A_A:D181N+A:S230G_mut.pdb	mol_804.sdf	7.4	37°C	[(0.21, '140'), (2.8, '140'), (2.8, '140'), (0.21, '140')]	[(0.21, '140'), (2.8, '140')]	7.4	37°C	-----	Effect of ions not considered for the model
3.5.3.1	Homo sapiens	2AEB_A_A:S230G_mut.pdb	mol_804.sdf	7.4	37°C	"[(0.8, '140'), (0.08, ""{83: 'Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc. Natl. Acad. Sci,2005', 140: 'The second-shell metal ligands of human arginase affect coordination of the nucleophile and substrate,2010'}""), (0.08, ""{83: 'Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc. Natl. Acad. Sci,2005', 140: 'The second-shell metal ligands of human arginase affect coordination of the nucleophile and substrate,2010'}""), (0.8, '140')]"	[(0.8, '140'), (0.08, '83')]	7.4	37°C	-----	Effect of ions not considered for the model
3.5.3.1	Homo sapiens	2AEB_A_A:S230C_mut.pdb	mol_804.sdf	7.4	37°C	"[(2.1, '140'), (0.15, ""{140: 'The second-shell metal ligands of human arginase affect coordination of the nucleophile and substrate,2010'}""), (0.15, ""{140: 'The second-shell metal ligands of human arginase affect coordination of the nucleophile and substrate,2010'}""), (2.1, '140')]"	[(2.1, '140'), (0.15, '140')]	7.4	37°C	-----	Effect of ions not considered for the model
3.5.99.6	Escherichia coli	1FS5_A_A:C118S+A:C228S+A:C239S_mut.pdb	mol_1945.sdf	7.5	30°C	"[(0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33'), (5.1, ""{33: 'Site-directed fluorescence labeling reveals differences on the R-conformer of glucosamine 6-phosphate deaminase of Escherichia coli induced by active or allosteric site ligands at steady state,2005'}""), (0.46, '33')]"	(0.46, '33')	7.5	30°C	-----	Value from experiment considered instead of Hill's equation
3.8.1.5	Xanthobacter autotrophicus	1B6G_A_A:W175Y_mut.pdb	mol_4882.sdf	-----	-----	[(0.06, '17'), (60.0, '17'), (0.06, '17'), (59.0, '17'), (60.0, '17'), (0.06, '17'), (60.0, '17'), (59.0, '17'), (59.0, '17'), (0.06, '17'), (59.0, '17'), (60.0, '17')]	[(0.06, '17'), (60.0, '17'), (59.0, '17')]	-----	-----	-----	All values are correct
4.1.1.48	Saccharolobus solfataricus	4A29_A_A:D61C_mut.pdb	mol_4938.sdf	7.5	25°C	[(4.6e-05, '41'), (0.000109, '41'), (0.000109, '41'), (4.6e-05, '41')]	[(4.6e-05, '41'), (0.000109, '41')]	7.5	25°C	-----	Difference in fluorescent dyes not considered for model
4.1.2.13	Oryctolagus cuniculus	5TLE_A_A:K108M_mut.pdb	mol_3254.sdf	-----	-----	"[(0.0412, '139'), (0.15, ""{31: 'Characterization and comparison of soluble and immobilized pig muscle aldolases. Appl. Biochem,1985', 91: 'Hydroxynaphthaldehyde phosphate derivatives as potent covalent Schiff base inhibitors of fructose-1,6-bisphosphate aldolase,2005', 105: 'A thermostable variant of fructose bisphosphate aldolase constructed by directed evolution also shows increased stability in organic solvents. Protein Eng. Des,2004'}""), (0.15, ""{31: 'Characterization and comparison of soluble and immobilized pig muscle aldolases. Appl. Biochem,1985', 91: 'Hydroxynaphthaldehyde phosphate derivatives as potent covalent Schiff base inhibitors of fructose-1,6-bisphosphate aldolase,2005', 105: 'A thermostable variant of fructose bisphosphate aldolase constructed by directed evolution also shows increased stability in organic solvents. Protein Eng. Des,2004'}""), (0.0412, '139')]"	(0.0412, '139')	-----	-----	-----	Other value is incorrect in BRENDA (must be 0.015)
4.1.3.17	Pseudomonas putida	3NOJ_A_A:R195A_mut.pdb	mol_5055.sdf	8	25°C	[(1.37, '13'), (2.89, '13'), (2.89, '13'), (1.37, '13')]	(1.37, '13')	8	25°C	-----	Value in the absence of phosphate considered
4.1.3.17	Pseudomonas putida	3NOJ_A_A:G144V_mut.pdb	mol_5055.sdf	8	25°C	[(1.39, '13'), (6.83, '13'), (6.83, '13'), (1.39, '13')]	(1.39, '13')	8	25°C	-----	Value in the absence of phosphate considered
4.1.3.17	Pseudomonas putida	3NOJ_A_A:R40A_mut.pdb	mol_5055.sdf	8	25°C	[(0.304, '13'), (3.26, '13'), (3.26, '13'), (0.304, '13')]	(0.304, '13')	8	25°C	-----	Value in the absence of phosphate considered
4.2.1.1	Methanosarcina thermophila	1QRE_A_A:R93H_mut.pdb	mol_1136.sdf	7.5	37°C	[(25.0, '94'), (6.09, '94'), (6.09, '94'), (25.0, '94')]	(25.0, '94')	7.5	37°C	-----	Value in the absence of guanidine hydrochloride considered
4.2.1.1	Methanosarcina thermophila	1QRE_A_A:R93A_mut.pdb	mol_1136.sdf	7.5	37°C	"[(34.0, '94'), (15.7, '94'), (34.0, '94'), (17.1, '94'), (34.0, '94'), (12.8, '94'), (34.0, '94'), (26.2, '94'), (34.0, '94'), (14.5, '94'), (34.0, '94'), (12.2, '94'), (34.0, '94'), (16.2, '94'), (34.0, '94'), (9.45, '94'), (34.0, '94'), (25.4, '94'), (34.0, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (15.7, '94'), (34.0, '94'), (15.7, '94'), (17.1, '94'), (15.7, '94'), (12.8, '94'), (15.7, '94'), (26.2, '94'), (15.7, '94'), (14.5, '94'), (15.7, '94'), (12.2, '94'), (15.7, '94'), (16.2, '94'), (15.7, '94'), (9.45, '94'), (15.7, '94'), (25.4, '94'), (15.7, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (17.1, '94'), (34.0, '94'), (17.1, '94'), (15.7, '94'), (17.1, '94'), (12.8, '94'), (17.1, '94'), (26.2, '94'), (17.1, '94'), (14.5, '94'), (17.1, '94'), (12.2, '94'), (17.1, '94'), (16.2, '94'), (17.1, '94'), (9.45, '94'), (17.1, '94'), (25.4, '94'), (17.1, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (12.8, '94'), (34.0, '94'), (12.8, '94'), (15.7, '94'), (12.8, '94'), (17.1, '94'), (12.8, '94'), (26.2, '94'), (12.8, '94'), (14.5, '94'), (12.8, '94'), (12.2, '94'), (12.8, '94'), (16.2, '94'), (12.8, '94'), (9.45, '94'), (12.8, '94'), (25.4, '94'), (12.8, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (26.2, '94'), (34.0, '94'), (26.2, '94'), (15.7, '94'), (26.2, '94'), (17.1, '94'), (26.2, '94'), (12.8, '94'), (26.2, '94'), (14.5, '94'), (26.2, '94'), (12.2, '94'), (26.2, '94'), (16.2, '94'), (26.2, '94'), (9.45, '94'), (26.2, '94'), (25.4, '94'), (26.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (14.5, '94'), (34.0, '94'), (14.5, '94'), (15.7, '94'), (14.5, '94'), (17.1, '94'), (14.5, '94'), (12.8, '94'), (14.5, '94'), (26.2, '94'), (14.5, '94'), (12.2, '94'), (14.5, '94'), (16.2, '94'), (14.5, '94'), (9.45, '94'), (14.5, '94'), (25.4, '94'), (14.5, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (12.2, '94'), (34.0, '94'), (12.2, '94'), (15.7, '94'), (12.2, '94'), (17.1, '94'), (12.2, '94'), (12.8, '94'), (12.2, '94'), (26.2, '94'), (12.2, '94'), (14.5, '94'), (12.2, '94'), (16.2, '94'), (12.2, '94'), (9.45, '94'), (12.2, '94'), (25.4, '94'), (12.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (16.2, '94'), (34.0, '94'), (16.2, '94'), (15.7, '94'), (16.2, '94'), (17.1, '94'), (16.2, '94'), (12.8, '94'), (16.2, '94'), (26.2, '94'), (16.2, '94'), (14.5, '94'), (16.2, '94'), (12.2, '94'), (16.2, '94'), (9.45, '94'), (16.2, '94'), (25.4, '94'), (16.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (9.45, '94'), (34.0, '94'), (9.45, '94'), (15.7, '94'), (9.45, '94'), (17.1, '94'), (9.45, '94'), (12.8, '94'), (9.45, '94'), (26.2, '94'), (9.45, '94'), (14.5, '94'), (9.45, '94'), (12.2, '94'), (9.45, '94'), (16.2, '94'), (9.45, '94'), (25.4, '94'), (9.45, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (25.4, '94'), (34.0, '94'), (25.4, '94'), (15.7, '94'), (25.4, '94'), (17.1, '94'), (25.4, '94'), (12.8, '94'), (25.4, '94'), (26.2, '94'), (25.4, '94'), (14.5, '94'), (25.4, '94'), (12.2, '94'), (25.4, '94'), (16.2, '94'), (25.4, '94'), (9.45, '94'), (25.4, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (34.0, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (15.7, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (17.1, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (12.8, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (26.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (14.5, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (12.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (16.2, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (9.45, '94'), (11.7, ""{94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 341: 'DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J. Med,2012'}""), (25.4, '94')]"	(15.7, '94')	7.5	37°C	-----	Value in the absence of cosubstrates considered
4.2.1.1	Methanosarcina thermophila	1QRE_A_A:R93C_mut.pdb	mol_1136.sdf	7.5	37°C	"[(17.3, '94'), (47.6, '94'), (17.3, '94'), (13.6, '94'), (17.3, '94'), (34.2, '94'), (17.3, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (47.6, '94'), (17.3, '94'), (47.6, '94'), (13.6, '94'), (47.6, '94'), (34.2, '94'), (47.6, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (13.6, '94'), (17.3, '94'), (13.6, '94'), (47.6, '94'), (13.6, '94'), (34.2, '94'), (13.6, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (34.2, '94'), (17.3, '94'), (34.2, '94'), (47.6, '94'), (34.2, '94'), (13.6, '94'), (34.2, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (17.3, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (47.6, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (13.6, '94'), (6.5, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002'}""), (34.2, '94')]"	(34.2, '94')	7.5	37°C	-----	Value in the absence of cosubstrates considered
4.2.1.1	Methanosarcina thermophila	1QRE_A_A:R93K_mut.pdb	mol_1136.sdf	7.5	37°C	[(16.3, '94'), (19.1, '94'), (16.3, '94'), (33.4, '94'), (19.1, '94'), (16.3, '94'), (19.1, '94'), (33.4, '94'), (33.4, '94'), (16.3, '94'), (33.4, '94'), (19.1, '94')]	(33.4, '94')	7.5	37°C	-----	Value in the absence of guanidine hydrochloride considered
4.2.1.1	Methanosarcina thermophila	1QRE_A_A:R93E_mut.pdb	mol_1136.sdf	7.5	37°C	"[(51.4, '94'), (19.3, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 200: 'Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates. Bioorg. Med. Chem,2008'}""), (19.3, ""{86: 'A structure-function study of a proton transport pathway in teh gamma-class carbonic anhydrase from Methanosarcina thermophila,2000', 94: 'Role of the arginine 59 in the gamma-class carbonic anhydrases,2002', 200: 'Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates. Bioorg. Med. Chem,2008'}""), (51.4, '94')]"	(51.4, '94')	7.5	37°C	-----	Value in the absence of guanidine hydrochloride considered
4.98.1.1	Homo sapiens	3HCN_B_B:K879N_mut.pdb	mol_825.sdf	-----	-----	[(0.0232, '68'), (0.1101, '68'), (0.1101, '68'), (0.0232, '68')]	 (0.1101, '68')	-----	-----	-----	Value of homodimer considered
4.98.1.1	Homo sapiens	3HCN_B_B:C736Y_mut.pdb	mol_5262.sdf	-----	-----	"[(0.0302, '68'), (0.0129, ""{68: 'Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases,2005'}""), (0.0129, ""{68: 'Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases,2005'}""), (0.0302, '68')]"	(0.0302, '68')	-----	-----	-----	Value of homodimer considered
6.3.4.4	Escherichia coli	2GCQ_A_A:V274N_mut.pdb	mol_1825.sdf	7.7	25°C	"[(0.18, '53'), (0.021, ""{53: 'Determinants of L-L-aspartate and IMP recognition in Escherichia coli adenylosuccinate synthetase. J. Biol,2002', 62: 'Cavitation as a mechanism of substrate discrimination by adenylosuccinate synthetases,2006'}""), (0.021, ""{53: 'Determinants of L-L-aspartate and IMP recognition in Escherichia coli adenylosuccinate synthetase. J. Biol,2002', 62: 'Cavitation as a mechanism of substrate discrimination by adenylosuccinate synthetases,2006'}""), (0.18, '53')]"	(0.021, '53')	7.7	25°C	-----	Value without hydroxylamine considered
6.3.4.4	Escherichia coli	2GCQ_A_A:V274A_mut.pdb	mol_211.sdf	7.7	25°C	[(0.14, '53'), (0.017, '53'), (0.017, '53'), (0.14, '53')]	(0.017, '53')	7.7	25°C	-----	Value without hydroxylamine considered
6.3.5.2	Escherichia coli	1GPM_A_A:H186E+A:E383H_mut.pdb	mol_5511.sdf	8.5	37°C	"[(0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57'), (0.05, ""{57: 'Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase. Arch. Biochem,2014'}""), (0.008, '57')]"	(0.008, '57')	8.5	37°C	-----	Value of overall reaction considered
6.3.5.2	Escherichia coli	1GPM_A_A:E383A_mut.pdb	mol_5511.sdf	8.5	37°C	[(0.022, '57'), (0.056, '57'), (0.056, '57'), (0.022, '57')]	(0.022, '57')	8.5	37°C	-----	Value of overall reaction considered
6.3.5.2	Escherichia coli	1GPM_A_A:H186A+A:E383A_mut.pdb	mol_5511.sdf	8.5	37°C	[(0.007, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.007, '57'), (0.074, '57'), (0.007, '57')]	(0.007, '57')	8.5	37°C	-----	Value of overall reaction considered
